# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-25-071169
Filing Date
2025-05-14
Accepted
2025-05-14 13:49:07
Documents
16
Period of Report
2025-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | neog-20250514.htm iXBRL | 8-K | 41399
2 | EX-99.1 | neog-ex99_1.htm | EX-99.1 | 7538
3 | GRAPHIC | neog-ex99_1s1.jpg | GRAPHIC | 463714
4 | GRAPHIC | neog-ex99_1s2.jpg | GRAPHIC | 589241
5 | GRAPHIC | neog-ex99_1s3.jpg | GRAPHIC | 332322
6 | GRAPHIC | neog-ex99_1s4.jpg | GRAPHIC | 516382
| Complete submission text file | 0000950170-25-071169.txt |  | 2784758

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | neog-20250514.xsd | EX-101.SCH | 25023
18 | EXTRACTED XBRL INSTANCE DOCUMENT | neog-20250514_htm.xml | XML | 4730

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 25944338
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)